Glycinebisacodyl sodium can enhance the therapeutic effect of radiotherapy. Glycosaminidazole sodium is a kind of radiosensitizing drug, which is suitable for patients undergoing radiation therapy for head and neck tumors, esophageal cancer, lung cancer and other solid tumors, and it can improve the sensitivity of tumors to radiation, and increase the therapeutic effect of radiotherapy; however, it should be noted that the use of this product alone can not play a role in the treatment of tumors. The use of this product can produce nausea and vomiting, skin rash, muscle tremor, palpitations (rapid heartbeat, often accompanied by panic), cardiac arrhythmia, electrocardiogram changes and other adverse reactions; pregnant women, as well as breastfeeding women are prohibited; patients with abnormal liver, kidney and cardiac function is prohibited to use glycosaminoglycosides sodium. Patients should use this product under the guidance of a physician’s interview, pay attention to the adverse reactions, contraindications and precautions for the use of the drug. If you feel unwell during the use of glycosaminoglycoside sodium, you should contact your attending physician.